Bob Dagher
Technik-/Wissenschafts-/F&E-Leiter bei BRAINSTORM CELL THERAPEUTICS INC.
Vermögen: 134 596 $ am 30.04.2024
Profil
Dr. Bob Dagher, MD, is a Chief Medical Officer & Executive Vice President at Brainstorm Cell Therapeutics, Inc. Dr. Dagher was previously employed as a Chief Medical Officer by Enveric Biosciences, Inc., a Chief Medical Officer-WCG MedAvante-ProPhase by Cadent Therapeutics, Inc., a Senior Medical Director by Covance, Inc., and a Chief Medical Officer by MedAvante-ProPhase, Inc. He received his undergraduate degree from Université de Bordeaux and an undergraduate degree from Faculté De Médecine Necker Enfants Malades Université.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.04.2024 | 253 000 ( 0,37% ) | 134 596 $ | 30.04.2024 |
Aktive Positionen von Bob Dagher
| Unternehmen | Position | Beginn |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 16.04.2024 |
Ehemalige bekannte Positionen von Bob Dagher
| Unternehmen | Position | Ende |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.12.2021 |
| COVANCE INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 |
| MedAvante-ProPhase, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Bob Dagher
| Université de Bordeaux | Undergraduate Degree |
| Faculté De Médecine Necker Enfants Malades Université | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Health Technology |
| MedAvante-ProPhase, Inc. |
